ルイジアナ州における脂肪肝の臨床試験
ルイジアナ州内の拠点で、脂肪肝に関する11件の研究が参加者を募集しています。
ルイジアナ州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Lafayette
- 89bio Clinical Study Site, Lake Charles
- 89bio Clinical Study Site, West Monroe
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Covington
- 89bio Clinical Study Site, Houma
- 89bio Clinical Study Site, Lake Charles
- 他2件
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/10/05更新 · NCT06318169A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Tandem Clinical Research, Plaza II, Metairie
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07527910A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Tandem Clinical Research, Metairie
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Delta Research Partners of Bastrop, LLC, Bastrop
- Tandem Clinical Research, Marrero
- Care Access - New Iberia, New Iberia
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Bastrop
- Akero Clinical Study Site, Covington
- Akero Clinical Study Site, Houma
- 他5件
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Marrero
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/17更新 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Tandem Clinical Research, Covington
- Tandem Clinical Research, Houma
- Tandem Clinical Research GI, LLC, Marrero
- 他4件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/09更新 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Marrero
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/08/03更新 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Bastrop
- GSK Investigational Site, Marrero
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/07/27更新 · NCT07221227A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Tandem Clinical Research, Marrero
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/04/16更新 · NCT05648214ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。